---
figid: PMC5043614__fonc-06-00205-g001
figlink: /pmc/articles/PMC5043614/figure/F1/
number: Figure 1
caption: (A) Molecular subclassification of triple-negative breast cancer (TNBC) based
  on gene expression profiling. Triple-negative breast cancers have been defined as
  tumors that are devoid of the expression of estrogen receptor (ER), progesterone
  receptor (PR), and human epidermal growth factor receptor 2 (HER2). TNBC overlap
  with (1) basal-like breast cancers; (2) BRCA-mutated tumors; (3) claudin-low tumors;
  (4) tumors overexpressing EGFR, associated with TP53 mutations or expressing cytokeratins;
  (5) tumors characterized by immune response signatures; and (6) tumors possessing
  some special histological types. (B) Schematic molecular pathway identified in TNBC.
  Multiple signaling cascades are activated in TNBC including those triggered by receptor
  tyrosine kinases (RTK), G protein-coupled receptor (GPCR), and integrins and their
  downstream effectors. Ras-mediated signaling commonly occurs through the RTK/growth
  factor receptor-bound protein 2 (Grb2)/Sos–Ras pathway. Ras directly interacts with
  and activates Raf. Raf phosphorylates and activates MEK, which in turn phosphorylates
  and activates MAPKs. Integrin engagement triggers several signaling cascades including
  those that are mediated by FAK, Src, and cdc42. Activation of RTK and other external
  stimuli lead to the activation of PI3K pathway. PI3K activates AKT (whereas PTEN
  inhibits this activation) and then mTOR. The G-proteins bind and activate phospholipase
  C and activate the nuclear factor kappa B (NF-κB) transcription factor. This network
  of cell signaling pathways result in the activation of transcription factors that
  drive genomic signature programs of dysregulated cell cycle progression, proliferation,
  invasion, and survival.
pmcid: PMC5043614
papertitle: Key Players in Choline Metabolic Reprograming in Triple-Negative Breast
  Cancer.
reftext: Egidio Iorio, et al. Front Oncol. 2016;6:205.
pmc_ranked_result_index: '16145'
pathway_score: 0.8027052
filename: fonc-06-00205-g001.jpg
figtitle: Molecular subclassification of triple-negative breast cancer (TNBC) based
  on gene expression profiling
year: '2016'
organisms: Homo sapiens
ndex: 3d51c7ef-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5043614__fonc-06-00205-g001.html
  '@type': Dataset
  description: (A) Molecular subclassification of triple-negative breast cancer (TNBC)
    based on gene expression profiling. Triple-negative breast cancers have been defined
    as tumors that are devoid of the expression of estrogen receptor (ER), progesterone
    receptor (PR), and human epidermal growth factor receptor 2 (HER2). TNBC overlap
    with (1) basal-like breast cancers; (2) BRCA-mutated tumors; (3) claudin-low tumors;
    (4) tumors overexpressing EGFR, associated with TP53 mutations or expressing cytokeratins;
    (5) tumors characterized by immune response signatures; and (6) tumors possessing
    some special histological types. (B) Schematic molecular pathway identified in
    TNBC. Multiple signaling cascades are activated in TNBC including those triggered
    by receptor tyrosine kinases (RTK), G protein-coupled receptor (GPCR), and integrins
    and their downstream effectors. Ras-mediated signaling commonly occurs through
    the RTK/growth factor receptor-bound protein 2 (Grb2)/Sos–Ras pathway. Ras directly
    interacts with and activates Raf. Raf phosphorylates and activates MEK, which
    in turn phosphorylates and activates MAPKs. Integrin engagement triggers several
    signaling cascades including those that are mediated by FAK, Src, and cdc42. Activation
    of RTK and other external stimuli lead to the activation of PI3K pathway. PI3K
    activates AKT (whereas PTEN inhibits this activation) and then mTOR. The G-proteins
    bind and activate phospholipase C and activate the nuclear factor kappa B (NF-κB)
    transcription factor. This network of cell signaling pathways result in the activation
    of transcription factors that drive genomic signature programs of dysregulated
    cell cycle progression, proliferation, invasion, and survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCB1
  - PLCB2
  - PLCB3
  - PTEN
  - RAF1
  - PRKCD
  - AKT2
  - PLCB4
  - PLCD1
  - PRKCE
  - TP53
  - MAPK1
  - MAP2K1
  - MAP2K2
  - PLCE1
  - PRKCI
  - PRKCQ
  - PRKCZ
  - AKT3
  - AKT1
  - NRAS
  - HRAS
  - BRCA1
  - PLCG1
  - PLCG2
  - PLCD4
  - PLCZ1
  - PLCD3
  - GRB2
  - SOS1
  - ERBB2
  - BRAF
  - ARAF
  - PIK3R4
  - PIK3CA
  - KRAS
  - SRC
  - MAPK14
  - PRKCA
  - PRKD3
  - PRKCG
  - MTOR
  - NFKB1
  - PIK3CB
  - PIK3R6
  - PIK3R5
  - MAPK8
  - MAPK11
  - PIK3CG
  - PIK3R3
  - PRKCB
  - MAPK12
  - CDC42
  - PTK2
  - PRKCH
  - SOS2
  - MAPK9
  - MAPK3
  - MAPK13
  - MAPK10
  - NMUR1
  - PIK3CD
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: BRCA1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: Grb2/SOS
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Grb2/SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: cdc42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Grb2/SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MẠPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
